The goal of practical photodynamic therapy (PDT) dosimetry is to optimize the distribution of a light dose delivered to tissue by selecting the irradiation time and geometry to match the geometry and optical properties of the tumor and surrounding tissue. Homogeneous irradiation is among one of the sources of correct PDT dosimetry. The goal of this study is to model and predict the influence of the shape of a treated organ in need of light dose correction. Thus efficiency of light delivery to the tissue volume is defined and calculated with shape factors of the uterine cervix as parameters. Two cases (parallel and divergent beam) of enlightening configuration are investigated. The calculations presented extend PDT dosimetry with the influence of the shape of the uterine cervix on PDT necrosis depth. This allows for photodynamic excitation light dose correction for more reliable treatments.
Introduction
Photodynamic therapy ͑PDT͒ and diagnosis ͑PDD͒ has become a recognized therapy and diagnostics tool for cancer treatment. This technique requires coexistence of at least three agents. A photosensitizer ͑PS͒, under light of proper fluence and wavelength, transforms chemical compounds ͑e.g., molecular oxygen O 2 ) to free radicals, which are directly responsible for local toxicity. Nevertheless, the efficiency of the treatment procedure is a complicated relation of the fluence of activating light, the initial concentration of the photosensitizer, and the fill-in coefficient of PS. For porphyrin derivatives and some other sensitizers, proper concentration of oxygen is required. In addition, these quantities and conditions may change during the treatment, due to photobleaching of the sensitizer, consumption of oxygen, variation of PS concentration, and others. The efficiency may also be patient and drug specific. In gynecological PDT, the menstrual cycle affects the fluorescence spectroscopy as a monitoring tool for dosimetry and diagnosis. 1 Calculating the excitation light dosage, one should then consider several aspects. Higher irradiance may cause thermal effects in the tissue, as well as rapid consumption of oxygen leading to photobleaching and phototransformation of the photosensitizer. 2, 3 These may decrease the effective concentration of the sensitizer, thus higher efficiency of the treatment must be obtained either by extending the time of treatment ͑lowering irradiance͒ or exciting by a fractionated light source. 4, 5 The photochemical modification of PS and oxygen consumption should also be considered during prolonged light exposure.
There is also a need to develop sensitizers absorbing longer wavelengths because of the deeper penetration of light into tissue not affected by hemoglobin absorption.
Moreover, radiation dosage absorbed by photosensitisers strongly depends on the enlightening configuration and uniformity of light coming directly from a source 6 or from a light applicator, 7, 8 as well as on the structure and morphology of the surface.
As we show, the complicated shape of the organ may also impact severely the efficiency of light penetration into the tissue, affecting all successive steps of the treatment procedure due to the nonhomogenous light dose delivery. There are not many attempts that consider the impact of the shape of the organ on the performance of PDT. 9, 10 There are two stages in the approach to PDT dosimetry. The first one is an attempt of direct measurement of drug concentration, light fluence, and oxygen concentration in vivo for individual patients. The measurement of these values is presently a challenge in ambulatory conditions. However, developing theoretical or phenomenological models or using neural networks may allow for prediction of the progress and monitoring of the treatment. There were also some approaches to build dosimetry theoretical models. [11] [12] [13] [14] [15] Starting from the theory of diffusion of light in tissue, Grossweiner developed a theory allowing the calculation of necrosis depth (z n ) for different geometries of excitation. 12 The aim of the study was to estimate the light dose efficiency and necrosis depth reduction with the physiological shape of the uterine cervix as an input parameter. The more real configuration of enlightening the uterine cervix with a microlens fiber ͑divergent light͒ was also examined qualitatively and compared with a parallel light configuration. The potential clinical application of the model will allow us to predict the additional time of light therapy or to improve light delivery for better effectiveness of PDT.
Methods
Let us assume in the first approximation that the uterine cervix is symmetrical in the shape. Let the I R , L 1 , and L 2 parameters describe the shape and the convexity of the organ. The meaning of these parameters is described in Fig. 1 . Note that they can be estimated or measured before treatment procedure to correct light dose.
There are several factors to include for calculating the effectiveness of therapeutical light delivery to the nonflat surface tissue volume. The first one is Fresnel losses due to the difference in the index of refraction on the air-tissue border.
This factor is sensitive to the angle of incidence ␣ x of radiation versus normal to the tissue surface ͑see Fig. 1͒ . The second factor-deflection angle ⌬␣ x -arises from divergency of the light source and impacts Fresnel losses as well. For the third factor, one should also consider the impact of the angle of incidence of the radiation versus normal to the surface (␣ x ϩ⌬␣ x angle, see Fig. 1͒ on the effective irradiance. This will further reduce the incident irradiance by the cos(␣ x ϩ⌬␣ x ) factor, especially for x close to L 2 . For a point light source, the distance between the light source and the tissue surface also affects the effective irradiance. This results from lowering the optical power per area, while increasing the distance between the light source and the enlightened surface. There is another factor influencing the effective incident irradiance, which in some cases cannot be neglected, but is difficult to consider quantitatively. The light, which is reflected and backscattered from the uterine cervix surface due to the Fresnel law, may undergo scattering or reflection from the surrounding vaginal tissue. The distance between the tissues during treatment is not close enough to play a major role in the irradiation ͑for the x close to L 2 case͒, however, one should be conscious about that process. The region (x close to L 2 ) suffers most from the decrease of irradiance. This is the hint for improving uniformity of light distribution for uterine cervix photodynamic cancer treatments.
One should also be conscious about nonideal roughness of the surface of the uterine cervix. This factor is very difficult to consider quantitatively due to patient-to-patient changes. Another factor not considered within the presented model is the intensity profile of the light source. We use an approximation of the top-hat intensity profile, which in some cases is not a real one.
Let us now quantitatively consider the Fresnel losses and the effective irradiance factors by introducing the effectiveness of light delivery to the tissue volume into the Grossweiner's model, where relation for necrosis depth is expressed as
͑1͒
The ␦ is the penetration depth, where energy density decreases down to 1/e of the initial value on the surface (E o t). The ␦ parameter depends on the wavelength of excitation and kind of tissue, but does not include absorption by blood. The knowledge of its value is critical for proper necrosis depth assessment, which has typical values of 1 to 3 mm for nonpigmented tissues in the red and near-IR spectral regions. The spectroscopic and optical properties of uterine cervix found in the literature 16 enabled us to calculate R d ϭ0.361 and the penetration depth ␦ϭ10.8 mm, which seems quite high. The 3 ϩ2bR d depends on the tissue optical constants and the mismatch between the refractive index of the tissue and the air. The bϭ3.115 parameter was obtained for a typical value of index of refraction (nϭ1.38) of tissue and internal reflectance coefficient (r i ϭ0.514). The threshold energy fluence parameter q* ͓Jm Ϫ2 ͔ strongly depends on the type and concentration of PDT drug and wavelength used. Unfortunately, photobleaching or pharmacokinetics also has a negative impact on its value.
The local enhancement of irradiance under the uterine cervix epidermis surface coming from scattering is considered by the application of diffuse reflection coefficient (R d ) in the dosimetry model described by Eq. ͑1͒.
However, to make the calculation of scaled necrosis depth (z n /␦) independent of the spectroscopic and optical properties of tissue, after applying simple relation ln(ab)ϭln(a) ϩln(b) to Eq. ͑1͒ and calculating the difference between flat ͑no Fresnel loss͒ and convex surface cases, one obtains
which is the scaled necrosis depth difference between convex and flat, no-loss enlightening configurations. This value informs us about the relative reduction of scaled necrosis depth (ln ) or light dose loss (1Ϫ), as the uterine cervix becomes convex more and more. The value is a product of Fresnel efficiency F and effective irradiance correction factors C and L . The C is the effective irradiance correction factor resulting from cosinus of the angle between the light ray and the tissue surface. The L corrects the effective irradiance due to change of distance between the point light source and the tissue surface.
Fresnel Losses
The Fresnel losses are due to the difference in the index of refraction on the air-tissue border. The losses change with the angle of light incidence ␣ x on the tissue surface. To calculate this angle, starting from boundary conditions, one can write an equation of a parabola in the xϭ0...L 2 range ͑see Fig. 1͒ . Assuming the symmetry of uterine cervix, the Eq. ͑3͒. describes its shape:
Calculating the first derivative of Eq. ͑3͒, one can easily obtain an angle of incidence of radiation versus normal to the
This is true for a parallel light beam. Using a microlens fiber, one changes the angle of incidence ͑see Fig. 1͒ . The calculation of deflection requires knowing the numerical aperture ͑NA͒ of the microlens and distance L 3 from fiber tip to the top of the uterine cervix. It was assumed that NA allows covering the circular area with the radius L 2 ϭ25 mm for arbitrary distance L 3 ϩI R . The deflection angle ͑see Fig. 1͒ can be then written as
͑5͒
For small x, one obtains lim
which is the parallel case. The calculations presented in the work for the divergent case are in fact the application of a point light source located at xϭ0 and at distance L 3 from the top of the uterine cervix. Using the Fresnel equation ͑see the Appendix in Sec. 5͒, which describes the amplitude relations of reflected to deflected beams depending on the angle of incidence, one can calculate the absolute transmission coefficient F ͑Fresnel ef-ficiency͒ through the border between air and tissue.
where A D and A I are amplitudes of deflected and incident rays, respectively, which are obtained from Fresnel equations for nonpolarized light. The n factor is a relative index of refraction. Because the beam goes through the border between air (nϳ1) and tissue (nϭ1.38 mean value for tissues͒, there is no danger for total internal reflection. The F versus dis-tance x, with convexity (I R ) and divergence (L 3 ) of a light source as parameters, is presented in Fig. 2͑a͒ . The Fresnel efficiency F (x) includes both incidence (␣ x ) and deflection angles (⌬␣ x ).
Effective Irradiance
The effective irradiance efficiency I depends on two factors. The first one is the cosinus factor C , describing the dependence of the irradiance on the angle between the incident ray and the normal to the surface:
for parallel beam source ⌬␣ x ϭ0. The dependence of the C versus distance x, with convexity (I R ) and divergence (L 3 ) of light source as parameters, is presented in Fig. 2͑b͒ .
The second factor, power density factor L , involves the distance between the light source and the tissue surface. It was assumed that at a distance L 3 ϩI R ͑the bottom of the uterine cervix͒, a point light source produces a cone with a radius of L 2 ϭ25 mm. The radius of a circular base of the cone for an arbitrary x position ͑see Fig. 1͒ is R Ix ϭL 2 (L 3 ϩI R ϪI x )/(L 3 ϩI R ), where I x ϭI(x,I R ,L 1 ,L 2 ). The area calculated at the top (I x ϭI R ) versus the area at I x height from the bottom of the uterine cervix was used for the power density correction factor L construction:
The dependence of the L versus distance x, with convexity (I R ) and divergence (L 3 ) of light source as parameters, is presented in Fig. 2͑c͒ . At the top of the uterine cervix (I x ϭI R ) L ϭ1.
Results
Combining Eqs. ͑6͒, ͑7͒, and ͑8͒ into Eq. ͑2͒, one can present dose efficiency ͓Figs. 3͑a͒ and 3͑b͔͒ or scaled necrosis depth reduction ⌬(z n /␦)ϭln ͓Figs. 3͑c͒ and 3͑d͔͒ versus the distance from the axis of symmetry.
Assuming that acceptable dose losses are 20% (ϭ0.8), one obtains from Figs. 3͑a͒ and 3͑b͒ that only the top of the uterine cervix is efficiently enlightened. The 20% dose loss gives about 22% of scaled necrosis depth reduction. A radius of acceptance is equal to 7.7, 8.8, and 9.4 mm for I R ϭ25 mm and a little larger, e.g., 10.5, 13.7, and 15.9 mm for I R ϭ10 mm. This points out the urgent need for a reliable uterine cervix PDT light dose delivery illuminator.
The considerations are general, but it is easy to apply them to clinical cases, when exact values of spectroscopic and optical properties of treated tissue are known. One should add the ⌬z n /␦ value to the scaled necrosis depth calculated for a specific case. This will allow for correction of the exposure time for proper photodynamic treatment.
To make the obtained result even more general, dose efficiency Јϭ F C ͓Fig. 4͑a͔͒ and scaled necrosis depth reduction ⌬(z n /␦)ϭln Јϭln F C ͓Fig. 4͑b͔͒ were presented versus the angle of incidence. The L was excluded from calculations due to an organ shape-specific dependence. The obtained relations are independent from I R ,L 1 , L 2 , and L 3 parameters, which in fact narrow down the angle range for a specific tissue shape. The 20% dose loss (Јϭ0.8) gives around 22% of scaled necrosis depth reduction, which occurs for around a 30-deg angle between the incident ray and tissue surface.
Conclusions
We demonstrate the influence of the shape of an enlightened organ on the efficiency of PDT treatment defined as a necrosis depth reduction and dose efficiency. Using the curvature of the uterine cervix, we model the light dose delivery efficiency on the border between air and tissue in the two enlightening configurations. The relative simplicity of the uterine cervix shape assessment (L 1 , L 2 , and I R in Fig. 1͒ and relative simplicity of the mathematical procedure of the correction coefficient calculation allows for direct considerations in patient-specific effectiveness of light therapy. The results are general, because the real degree of correction is organ-and enlightening-configuration specific. The relations developed in the work allow us to assess the increase of treatment time needed for successive treatment due to the shape of the cervix. The considerations can be used for light applicator modeling and construction, and for enhancement of therapeutical procedures.
Appendix A
The Fresnel relation for deflected rays is expressed as ͩ A D A I ͪ 2 ϭ ͫ 2 cos ␣•sin ␤ sin͑␣ϩ␤ ͒cos͑ ␣Ϫ␤͒ ͬ 2
•͓cos 2 ϩsin 2 cos 2 ͑ ␣Ϫ␤͔͒, ͑9͒
where A D and A I are amplitudes of deflected and incident rays, respectively, and the ␣ and ␤ variables are angles of incidence and deflection, respectively. For nonpolarized light, cos 2 ϭsin 2 ϭ0.5. The ␤ angle was calculated ͑as a function of angle of incidence ␣͒ from the known relation sin ␤ sin ␣ ϭ n 1 n 2 . ͑10͒
